Dr Marianne W. Mureithi, Director of the KAVI-Institute of Clinical Research (KAVI-ICR)  at the University of Nairobi, is a Co-Investigator on a newly announced CAD 2 million (5-year) international team grant funded by the Canadian Institutes of Health Research (CIHR) under its Bringing Biology to Cancer Prevention programme.

The study will examine how inflammation and hormonal changes influence HPV persistence and cervical cancer risk in menopausal women.

Led by Professor Keith Fowke (University of Manitoba), the Canada–Kenya research team includes Dr Julie Lajoie (University of Manitoba), Dr Joshua Kimani (PHDA/UoN), Dr Kenneth Omollo (PHDA/UoN), Prof Lyle McKinnon, and Dr Aida Sivro, working across a multidisciplinary Canada–Kenya research team.

This award reinforces the University of Nairobi’s growing leadership in global health research and strengthens Canada–Kenya scientific collaboration in advancing cervical cancer prevention.